Ayumi Taguchi Selected Research

Ayumi Taguchi Research Topics

Disease

28	Neoplasms (Cancer) 07/2022 - 01/2014
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2022 - 08/2012
11	Endometriosis 01/2021 - 01/2013
9	Inflammation (Inflammations) 07/2022 - 03/2014
7	Ovarian Neoplasms (Ovarian Cancer) 10/2019 - 01/2016
5	Ascites 03/2022 - 01/2016
5	Carcinoma (Carcinomatosis) 11/2020 - 04/2017
4	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2014
4	Endometrial Neoplasms (Endometrial Cancer) 03/2022 - 11/2017
4	Carcinogenesis 01/2022 - 06/2017
3	Infections 01/2022 - 01/2020
3	Adenomyosis 01/2021 - 01/2019
3	Premature Birth (Birth, Premature) 01/2017 - 11/2013
2	Febrile Neutropenia 03/2022 - 09/2021
2	Uterine Cervical Dysplasia 04/2021 - 01/2017
2	Ovarian Epithelial Carcinoma 10/2020 - 04/2019
2	Lymphopenia (Lymphocytopenia) 05/2020 - 04/2019
1	Disease Progression 07/2022
1	Papillomavirus Infections 04/2022
1	Respiratory Insufficiency (Respiratory Failure) 03/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2022
1	Melanoma (Melanoma, Malignant) 03/2022
1	Neutropenia 03/2022
1	Pulmonary Embolism 03/2022
1	Multiple Myeloma 01/2022
1	Pseudomyxoma Peritonei 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 09/2021
1	Diabetes Mellitus 05/2021
1	Hypertension (High Blood Pressure) 05/2021
1	Hypersensitivity (Allergy) 11/2020
1	Body Weight (Weight, Body) 10/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2020
1	Herpes Zoster 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 10/2019

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 12/2020 - 03/2014
6	Messenger RNA (mRNA)IBA 01/2021 - 03/2014
5	Histones (Histone)IBA 01/2022 - 01/2019
5	CytokinesIBA 01/2020 - 12/2015
4	Biomarkers (Surrogate Marker)IBA 05/2021 - 04/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2016
3	LigandsIBA 01/2021 - 11/2016
3	Histone MethyltransferasesIBA 12/2020 - 01/2019
3	Progestins (Progestagens)IBA 12/2019 - 01/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2018 - 03/2014
3	ResveratrolIBA 04/2016 - 03/2014
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2014 - 01/2013
2	AlbuminsIBA 05/2021 - 01/2019
2	GlobulinsIBA 05/2021 - 01/2019
2	LipopolysaccharidesIBA 01/2021 - 12/2015
2	SuspensionsIBA 01/2018 - 04/2017
2	Oncogene Proteins (Oncogene Protein)IBA 04/2015 - 08/2012
1	Immune Checkpoint InhibitorsIBA 07/2022
1	NivolumabIBA 07/2022
1	Papillomavirus Vaccines (HPV Vaccines)IBA 04/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022
1	fibrin fragment D (D-dimer)IBA 03/2022
1	pegfilgrastim (Neulasta)FDA Link 03/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2022
1	AntibodiesIBA 03/2022
1	Cisplatin (Platino)FDA LinkGeneric 03/2022
1	Desmoplakins (Desmoplakin)IBA 01/2022
1	human PRMT2 proteinIBA 01/2022
1	coactivator-associated arginine methyltransferase 1IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 01/2021
1	Progesterone FDA LinkGeneric 01/2021
1	ProstaglandinsIBA 01/2021
1	ChemokinesIBA 01/2021
1	Lysine (L-Lysine)FDA Link 12/2020
1	Pharmaceutical PreparationsIBA 11/2020
1	Carboplatin (JM8)FDA LinkGeneric 11/2020
1	DS-5272IBA 10/2020
1	MTOR InhibitorsIBA 10/2020
1	Everolimus FDA Link 10/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	dienogest FDA Link 12/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2019
1	ammonium trichloro(dioxoethylene-O,O'-)tellurate (AS 101)IBA 11/2019
1	AntralIBA 11/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2019
1	B7-H1 AntigenIBA 10/2019
1	Interleukin-17 (Interleukin 17)IBA 10/2019
1	LLY-507IBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Serum AlbuminIBA 01/2019
1	Serum GlobulinsIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2018
1	trametinibIBA 12/2018

Therapy/Procedure

12	Therapeutics 03/2022 - 05/2016
5	Drug Therapy (Chemotherapy) 03/2022 - 01/2011
4	Radiotherapy 09/2021 - 01/2020
2	Stem Cell Transplantation 12/2020 - 01/2020
2	Induction Chemotherapy 10/2020 - 04/2019
2	Immunotherapy 10/2019 - 10/2014
1	Adjuvant Chemotherapy 07/2022
1	Palliative Care (Palliative Therapy) 05/2021
1	Oral Administration 04/2021
1	Drug Tapering 10/2020
1	Molecular Targeted Therapy 10/2020